A certified medical cannabis facility in Thailand is adding a specialized mother room and advanced drying room as part of a capacity expansion aimed at international supply.
KAMBIS Community Enterprise Innovative Farming announced the build-out via LinkedIn, describing both rooms as near completion and central to its roadmap for scaling production. The company frames the investment as a prerequisite for consistent output across export markets, not simply a volume increase.
The expansion runs alongside an ongoing compliance push. KAMBIS has been working toward GACP and EU GMP readiness, a combination that reflects the standard required to supply regulated medical markets in Europe and elsewhere. The company noted that medical expertise has been embedded in its leadership from an early stage, a choice it says has kept clinical requirements at the center of cultivation decisions as the operation has grown.
The mother room addition is particularly notable in the context of international supply. Dedicated mother room infrastructure allows a facility to maintain genetic consistency across production cycles, which is a prerequisite for the kind of batch-to-batch reproducibility that EU GMP frameworks require. Drying room capacity, meanwhile, is frequently the bottleneck that limits how much compliant flower a cultivation site can move through post-harvest without compromising quality metrics.
For more information:
Kambis
kambis.co.th
